Zobrazeno 1 - 10
of 987
pro vyhledávání: '"Pettitt S"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yap T, Kristeleit R, Michalarea V, Pettitt S, Lim J, Carreira S, Roda D, Miller R, Riisnaes R, Miranda S, Figueiredo I, Nava Rodrigues D, Ward S, Matthews R, Parmar M, Turner A, Tunariu N, Chopra N, Gevensleben H, Turner N, Ruddle R, Raynaud F, Decordova S, Swales K, Finneran L, Hall E, Rugman P, Lindemann J, Foxley A, Lord C, Banerji U, Plummer R, Basu B, Lopez J, Drew Y, de Bono J
Publikováno v:
Cancer Discovery
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Preclinical studies have demonstrated synergy between poly(ADP-ribose) polymerase (PARP) and phosphatidylinositol-3-kinase (PI3K)/AKT pathway inhibitors in BRCA1 and BRCA2 (BRCA1/2)-deficient and BRCA1/2-proficient tumors. We conducted an investigato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::427df1bb8636f3a22173a38097ca6bf8
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4544
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4544
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Walker, C., Weekes, D., Torga, G., Quist, J., Trendell, J., Hitchens, L., Martin, A., Davidson, K., Kollarovic, G., Grigoriadis, A., Pines, J., Pettitt, S., Lord, C., Tutt, A.
Publikováno v:
In European Journal of Cancer October 2022 174 Supplement 1:S66-S66
Autor:
Stewart, J.R., Baxter, J., Zatreanu, D., Brough, R., Song, F., Konde, A., Krastev, D., Alexander, J., Natrajan, R., Pettitt, S., Banerjee, S., Lord, C.
Publikováno v:
In Annals of Oncology June 2022 33 Supplement 5:S383-S384
Autor:
Sumanasuriya S; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Seed G; The Institute of Cancer Research, University of London, London, UK., Parr H; The Institute of Cancer Research, University of London, London, UK., Christova R; The Institute of Cancer Research, University of London, London, UK., Pope L; The Institute of Cancer Research, University of London, London, UK., Bertan C; The Institute of Cancer Research, University of London, London, UK., Bianchini D; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Rescigno P; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Figueiredo I; The Institute of Cancer Research, University of London, London, UK., Goodall J; The Institute of Cancer Research, University of London, London, UK., Fowler G; The Institute of Cancer Research, University of London, London, UK., Flohr P; The Institute of Cancer Research, University of London, London, UK., Mehra N; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Neeb A; The Institute of Cancer Research, University of London, London, UK., Rekowski J; The Institute of Cancer Research, University of London, London, UK., Eisenberger M; Johns Hopkins University, Baltimore, MD, USA., Sartor O; Tulane Medical School, New Orleans, LA, USA., Oudard S; Hôpital Européen Georges Pompidou and Université de Paris, Paris, France., Geffriaud-Ricouard C; Sanofi-Genzyme, Paris, France., Ozatilgan A; Sanofi-Genzyme, Paris, France., Chadjaa M; Sanofi-Genzyme, Paris, France., Macé S; Sanofi-Genzyme, Paris, France., Lord C; The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Baxter J; The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Pettitt S; The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Lambros M; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Sharp A; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Mateo J; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Carreira S; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., Yuan W; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK., de Bono JS; The Institute of Cancer Research, University of London, London, UK; The Royal Marsden Hospital, London, UK. Electronic address: johann.de-bono@icr.ac.uk.
Publikováno v:
European urology [Eur Urol] 2021 Aug; Vol. 80 (2), pp. 243-253. Date of Electronic Publication: 2021 Jun 05.
Autor:
De Santis F; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fucà G; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany., Mantovani A; Istituto Clinico Humanitas IRCCS, Rozzano, Italy., Magnani L; Department of Surgery and Cancer, Imperial College London, London, UK., Lisanti M; Translational Medicine, School of Science, Engineering and Environment [SEE], Biomedical Research Centre [BRC], University of Salford, Greater Manchester, United Kingdom., Pettitt S; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom., Bellone M; Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy., Del Sal G; Department of Life Sciences, University of Trieste, 34127, Trieste, Italy., Minucci S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Eggermont A; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Bruzzi P; Unit of Clinical Epidemiology, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy., Bicciato S; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Noberini R; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Hiscott J; Laboratorio Pasteur, Istituto Pasteur-Fondazione Cenci-Bolognetti, 00161, Rome, Italy., De Braud F; Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Del Vecchio M; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Nicola M; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: massimo.dinicola@istitutotumori.mi.it.
Publikováno v:
Cytokine & growth factor reviews [Cytokine Growth Factor Rev] 2021 Jun; Vol. 59, pp. 1-8. Date of Electronic Publication: 2021 Feb 14.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.